CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Noninvasive ventilation in COVID-19 patients aged ≥ 70 years—a prospective multicentre cohort study
Authors
Hazem Maarouf Abosheaishaa
Yasmin Khairy Nasr Eldin Mohamed Ali
+48 more
Finn H. Andersen
Kasper Andersen
Antonio Artigas
Mohammed A. Azab
Ahmed Y. Azzam
Ida Riise Balleby
Michael Beil
Anders Thais Bjerregaard
Bernardo Bollen Pinto
Helene Brix
Raphael Romano Bruno
Jens Brushoej
Helle Bundgaard
Maurizio Cecconi
Cyril Charron
Dylan W. De Lange
Yumna A. Elgazzar
Philipp Eller
Jesper Fjølner
Hans Flaatten
Jakub Fronczek
Arnaud Galbois
Emmanuel Guerot
Bertrand Guidet
Ayman abdelmawgoad habib
Maria Aagaard Hansen
Aliae A.R.Mohamed Hussein
Michael Joannidis
Christian Jung
Susannah Leaver
Brian Marsh
Dieter Mesotten
Rui Moreno
Helene Korvenius Nedergaard
Sandra Oeyen
Kamil Polok
Pascal Reper
Rehab Salah
Joerg C. Schefold
Dorota Studzińska
Sigal Sviri
Walter Swinnen
Wojciech Szczeklik
Samar Tharwat
Stine Uhrenholt
Maja Villefrance
Kyrillos Wassim
Bernhard Wernly
Publication date
22 July 2022
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Funding Information: COVIP study did not have any funding. Publication of this article was funded by the Priority Research Area qLife under the program “Excellence Initiative – Research University” at the Jagiellonian University in Krakow (06/IDUB/2019/94). Publisher Copyright: © 2022, The Author(s).Background: Noninvasive ventilation (NIV) is a promising alternative to invasive mechanical ventilation (IMV) with a particular importance amidst the shortage of intensive care unit (ICU) beds during the COVID-19 pandemic. We aimed to evaluate the use of NIV in Europe and factors associated with outcomes of patients treated with NIV. Methods: This is a substudy of COVIP study—an international prospective observational study enrolling patients aged ≥ 70 years with confirmed COVID-19 treated in ICU. We enrolled patients in 156 ICUs across 15 European countries between March 2020 and April 2021.The primary endpoint was 30-day mortality. Results: Cohort included 3074 patients, most of whom were male (2197/3074, 71.4%) at the mean age of 75.7 years (SD 4.6). NIV frequency was 25.7% and varied from 1.1 to 62.0% between participating countries. Primary NIV failure, defined as need for endotracheal intubation or death within 30 days since ICU admission, occurred in 470/629 (74.7%) of patients. Factors associated with increased NIV failure risk were higher Sequential Organ Failure Assessment (SOFA) score (OR 3.73, 95% CI 2.36–5.90) and Clinical Frailty Scale (CFS) on admission (OR 1.46, 95% CI 1.06–2.00). Patients initially treated with NIV (n = 630) lived for 1.36 fewer days (95% CI − 2.27 to − 0.46 days) compared to primary IMV group (n = 1876). Conclusions: Frequency of NIV use varies across European countries. Higher severity of illness and more severe frailty were associated with a risk of NIV failure among critically ill older adults with COVID-19. Primary IMV was associated with better outcomes than primary NIV. Clinical Trial RegistrationNCT04321265, registered 19 March 2020, https://clinicaltrials.gov.publishersversionpublishe
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Repositório da Universidade Nova de Lisboa
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:run.unl.pt:10362/143540
Last time updated on 28/09/2022